NRC Health Q1 EPS Plunges 44% to $0.14 Despite Modest Revenue Growth
NRC sits 66% above its 52-week low of $11.014 on light trading volume (0.2× avg).
Summary
NRC Health reported its first-quarter 2026 results, revealing a significant decline in profitability. Diluted EPS fell 44% year-over-year to $0.14, and net income decreased 44.3% to $3.22M. This substantial drop in earnings occurred despite a modest 3.7% increase in revenue to $34.8M. The company attributed the decline in net income and EPS to continued investments in brand and product, including higher IT contractor and software spend, as well as increased depreciation and amortization from headquarters renovations completed in June 2025. The significant reduction in profitability is a material concern for investors and could lead to negative stock price movement. Traders will be closely watching future quarters to see if these investments translate into improved earnings.
At the time of this announcement, NRC was trading at $18.23 on NASDAQ in the Technology sector, with a market capitalization of approximately $399.4M. The 52-week trading range was $11.01 to $22.79. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.